#China #Algeness #AAT

Exciting Milestone in Aesthetic Treatments: Algeness® VL Approved in China

Advanced Aesthetic Technologies, Inc. (AAT) has reached a significant milestone in the world of aesthetic medicine with the recent approval of their product, Algeness® VL, for marketing in China. This groundbreaking agarose-based dermal filler has been developed to address the common aesthetic concerns of facial wrinkles and volume loss. AAT's partner in China, Lanzhou Biotechnique Development Co., Ltd. (LanDev), has successfully secured the necessary regulatory approvals to introduce this innovative product to the vast Chinese market.

The First of Its Kind

Algeness® VL is distinguished as the first injectable filler containing agarose to receive official clearance in China. This achievement highlights the rigorous research and development process behind the product, which is designed to be a natural and biodegradable solution free from synthetic additives. With a composition that utilizes a 2.5% agarose gel, Algeness® VL promises not only safety but also effective volumization for various facial enhancements.

AAT has collaborated closely with LanDev, a subsidiary of China National Biotec Group Company Limited (CNBG), leveraging their expertise to ensure successful integration and distribution of Algeness® VL within the Chinese market. Doug Abel, CEO of AAT, expressed enthusiasm about this partnership, stating that it positions them advantageously for success due to CNBG's strong market presence.

Research and Development: Years in the Making

The development of Algeness® has spanned several years of comprehensive scientific and clinical research. It culminates in a filler that offers aesthetically pleasing and long-lasting results while being fully compatible with the body's tissues. Dr. Omer Buhsem, a plastic surgeon based in Istanbul and Algeness®'s medical director, emphasized the product's unique properties, which allow for the precise shaping and contouring of facial features using techniques that ensure patient safety.

In addition, Algeness®’s positive reception among aesthetic specialists worldwide underscores its effectiveness. Dr. Tatjana Pavicic, a dermatologist from Munich, noted the